Home
About
Reports
Portfolio Strategy
Quantitative
Economic Research
Washington Policy Research
Technical Analysis
China Strategy
European Strategy
Commodities
Shoot Around
Derivatives Strategy
AI Macro Nexus Research
Contact
Sign Up
Login
Home
About
Reports
Portfolio Strategy
Quantitative
Economic Research
Washington Policy Research
Technical Analysis
China Strategy
European Strategy
Commodities
Shoot Around
Derivatives Strategy
AI Macro Nexus Research
Contact
Sign Up
Login
Washington Policy Research:
“BBB” Prescription Drug Outlook
Kim Wallace
December 7, 2021
12:44 PM
Publicly Traded Companies and Nationalism
Kim Wallace
December 7, 2021
8:27 AM
2022 Agenda Eclipses 2021 Unfinished Business
Kim Wallace
December 5, 2021
7:58 PM
Small Stuff of Bigger Import
Kim Wallace
December 3, 2021
7:40 AM
Fiscal Disappointment Possible, Fiscalamity Not
Kim Wallace
December 2, 2021
6:44 AM
US Banks’ Strength Frame Regulatory Agenda
Kim Wallace
December 1, 2021
6:56 AM
« Previous
Page
1
…
Page
64
Page
65
Page
66
Page
67
Page
68
…
Page
77
Next »
Passion, Integrity, Excellence, Collaboration.
Invest intelligently with 22V Research.
Click here to become a client and access our research.
Sign Up
Log In
